RN

Active Director Director DIN 09000923
DIN 09000923 First appointment Dec 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Rajat Nag

Data last updated:

Rajat Nag is a Director at Altep Lifesciences Private Limited (since 2020). The company operates in Chemicals. Altep Lifesciences Private Limited reported revenue of ₹5.7 Lakh (FY 2024).

DIN 09000923
Primary Designation Director
Industry Chemicals
First Appointment 17 Dec 2020
Oldest Company Age 5 yrs
Largest company Altep Lifesciences Private Limited · ₹5.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Altep Lifesciences Private Limited U24230UP2020PTC139413
Director17 Dec 20202020₹5.7 Lakh (FY 2024)Active

Board colleagues of Rajat Nag

NameDINCompanyDesignation
Shubham Kumar Nag09000922Altep Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Altep Lifesciences Private Limited
Premium access

Shareholding and investment profile for Rajat Nag

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajat Nag

Rajat Nag currently holds 1 directorship: Altep Lifesciences Private Limited (Director, since 17 Dec 2020, revenue ₹5.7 Lakh (FY 2024)).

Rajat Nag was first appointed on 17 Dec 2020 as Director at Altep Lifesciences Private Limited.

The current boards of Rajat Nag's companies include Shubham Kumar Nag (Altep Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available